CDKN2AIPNLP2

Across TCGA pan-cancer cohorts, CDKN2AIPNLP2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CDKN2AIPNLP2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where CDKN2AIPNLP2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDKN2AIPNLP2 is over-expressed in tumor.

STAD are the cancer types where CDKN2AIPNLP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDKN2AIPNLP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.059	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

CDKN2AIPNLP2–STAD

Open the STAD breakdown →